Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 31.74
-0.998 %
$ 1.77 B
Market Cap
24.05
P/E
SUPN - COST OF REVENUE
Cost of Revenue SUPN - Supernus Pharmaceuticals, Inc.
83.8 M
LAST VALUE
5.65%
2 YEAR CAGR
40.40%
5 YEAR CAGR
54.18%
10 YEAR CAGR